169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Methods of treating diabetes
#6302Atherosclerosis genes and related reagents and methods of use thereof
#6303Computerized systems and methods for assessment of genetic test results
#6304Gastrin hormone immunoassays
#6305Methods and devices for diagnosis of appendicitis
#6306Systems and methods for characterizing kidney diseases
#6307Method and kit for the early detection of impaired renal status
#6308Predicting mortality and detecting severe disease
#6309Monoclonal antibodies to progastrin
#6310Use of the receptor GPR86
#6311Method for examining kidney diseases
#6312ISLR gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof
#6313Diagnosis and treatment of human kidney diseases
#6314DIFFERENTIALLY EXPRESSED GENES RELATED TO CORONARY ARTERY DISEASE
#6315Marker useful for detection and measurement of free radical damage and method
#6316Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders
#6317Method and system for predicting liver fibrosis and related pathologies
#6318Methods for evaluating osteoarthritis risk
#6319Rapid Determination of Hepatocyte Growth Factor (Hgf) in the Body Fluids
#6320Methods for Modulating an Immune Response by Modulating Krc Activity
#6321METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF DISEASES OF THE AORTA
#6322Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
#6323Recombinant 12-KDA protein useful for the detection of respiratory allergies
#6324Connective Tissue Growth Factor-4
#6325Methods for testing for caloric restriction (CR) mimetics
#6326Diabetes-associated markers and methods of use thereof
#6327Differentially Expressed Genes Related to Coronary Artery Disease
#6328Use of soluble FLT-1 and its fragments in cardiovascular conditions
#6329Method of Predicting a Benefit of Antioxidant Therapy for Prevention of Cardiovascular Disease in Hiperglycemic Patients
#6330Human Obesity Susceptibility Gene and Uses Thereof
#6331Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determination
#6332Diagnostic markers for sub-acute ruminal acidosis
#6333Cancer-associated antigens and methods of their identification and use
#6334Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
#6335Prognostic Methods for Congestive Heart Failure
#6336Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
#6337Folate Antagonists Having Improved Selectivity
#6338Methods for identifying analgesic agents
#6339Therapeutic target and diagnostic marker for asthma and related conditions
#6340Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation
#6341Methods And Compositions For The Prevention And Treatment Of Gentiourinary Disorders Including Pre-Term Labor And Leiomyomas
#6342Method of diagnosing osteoarthritis
#6343Methods of treating inflammatory and autoimmune diseases with natalizumab
#6344Methods Of Regulating Metabolism And Mitochondrial Function
#6345Diagnostics And Therapeutics For Diseases Associated With Arginyl Aminopeptidase Rnpep (Rnpep)
#6346BIOMARKERS FOR ALS
#6347Allergenic proteins and peptides from dog dander and uses therefor
#6348Method of diagnosis of obesity
#6349Therapeutic agent for ulcerative colitis
#6350Methods for improving the recovery of troponin I and T in membranes, filters and vessels
#6351Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
#6352Osteogenic compositions comprising an amino acid sequence capable of being phosphorylated by CAMK2
#6353Inhibition of s6 kinaze activity for the treatment of insulin resistance
#6354Methods of assessing susceptibility to drug-induced thrombocytopenia
#6355Information acquisition apparatus on concentration of thioredoxins in sample, stress level information acquisition apparatus and stress level judging method
#6356Detection and determination of the stages of coronary artery disease
#6357Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
#6358Diagnostic method for identifying carriers of the Marburg I variant of factor VII-activating protease (FSAP) on the basis of differential modulation of FSAP activity
#6359Methods and kits using a molecular interaction between a Smurf-1 WW domain and LIM mineralization protein isoforms
#6360Method of detecting the presence of asthma or allergies in a patient
#6361Treatment of complement-associated disorders
#6362Use of A33 antigens and JAM-IT
#6363Categorically ranking animals for feed efficiency
#6364Method of diagnosing Sjogren's syndrome
#6365Rapid nasal assay kit
#6366Diagnosis or treatment of endothelial cell dysfunction related diseases
#6367Method of diagnosing diseases relating to endometriosis
#6368Biomarkers for liver fibrotic injury
#6369Compositions and methods for the treatment of immune related diseases
#6370METHODS AND COMPOSITIONS FOR DIAGNOSIS AND IMMUNOTHERAPY OF POLLEN ALLERGY
#6371Hedgehog Kinases and Their Use in Modulating Hedgehog Signaling
#6372Multi-analyte diagnostic test for thyroid disorders
#6373Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#6374Method for detecting leptin receptor ligands
#6375Detecting and predicting pre-eclampsia
#6376Methods of identifying adipocyte specific genes, the genes identified, and their uses
#6377METHOD FOR DIAGNOSING LIVER FIBROSIS
#6378METHOD FOR DIAGNOSING LIVER FIBROSIS
#6379Inhibitors of gob-4 protein as asthma therapeutics
#6380Methods of diagnosing atherosclerosis by measuring ApoCI
#6381Purified active HCV NS2/3 protease
#6382Liver disease-related methods and systems
#6383Latent protein C assays and their uses for diagnosis and/or prognosis in systemic inflammatory response syndromes
#6384Measuring troponin antibodies to assess cardiovascular risk
#6385Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#6386Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#6387GDF3 antibodies and related methods
#6388Remedy for cardiac failure containing ask1 inhibitor as active ingredient and method for screening the same
#6389Functional immunoassay
#6390Method for predicting sepsis or an acute infectious inflammatory response
#6391Diagnostic method for stroke
#6392Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy
#6393Ion channel
#6394Isolated antibodies against biologically active leptin-related peptides
#6395Method and system for determining whether additional laboratory tests will yield values beyond a threshold level
#6396Ceruloplasmin Assay
#6397DIAGNOSTIC METHOD OF MUCOPOLYSACCHARIDOSES
#6398PRO87299 polypeptides
#6399Purified active HCV NS2/3 protease
#6400Method for reducing ultraviolet light induced apoptosis
#6401Using a biological recording to obtain time values
#6402Time-resolved non-invasive optometric device for medical diagnostic
#6403TIME-RESOLVED NON-INVASIVE OPTOMETRIC DEVICE FOR DETECTING DIABETES
#6404Methods and means for treating protein conformational disorders
#6405Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease
#6406Development of human monoclonal antibodies and uses thereof
#6407Method for assessing disease states by profile analysis of isolated circulating endothelial cells
#6408Identification of antigen epitopes
#640944 Human Secreted Proteins
#641087 Human Secreted Proteins
#6411Biomarkers for kidney diseases and method for using same
#6412Uses of dna binding proteins
#6413Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
#6414Kits for assays of rapid screening of diabetes
#6415A KIT FOR ASSESSING THE PRO-INFLAMMATORY IMMUNE HEALTH OF AN INDIVIDUAL
#6416Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-α
#6417Methods for treating irritable bowel syndrome
#6418Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis
#6419METHOD OF DIAGNOSING CHRONIC DIARRHEA
#6420Methods of determination of activation or inactivation of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) hormonal systems
#6421Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein
#6422Methods of treating cancer, arthritis and/or diabetes with angiopoietins
#6423Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 6(edg6)
#6424Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
#6425Method for the rapid diagnosis of targets in human body fluids
#6426Measurement of cytoskeletal proteins and uses thereof in diagnosis, prognosis and therapy
#6427Methods and compositions for protein-hydroxy apatite complexes and their application in testing and modulating immunological system including a novel in vitro test for the detection of antibodies against calcium binding protein-hydroxy apatite complexes
#6428Assays and methods using biomarkers
#6429Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
#6430Compositions and articles for detection of analytes exceeding a pre-set threshold
#6431Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
#6432Diagnostic assay for stroke
#6433Insulin epitopes for the treatment of type 1 diabetes
#6434Secreted polypeptide species associated with cardiovascular disorders
#6435Single nucleotide polymorphisms sensitively predicting adverse drug reactions (adr) and drug efficacy
#6436Therapeutic, prophylactic and diagnostic agents
#6437COMPOSITIONS COMPRISING ANTIBODIES TO HUMAN FGL2
#6438GLP-1 agonists, compositions, methods and uses
#6439Anti-α2 integrin antibodies and their uses
#6440Methods for the prediction of arrhythmias and prevention of sudden cardiac death
#6441Mitochondrial markers of ischemia
#6442Methods of diagnosing and treating diabetes and insulin resistance
#6443Methods for isolating proteons from plasma samples
#6444Methods for the treatment of anxiety and for identification of anxiolytic agents
#6445Compositions and methods for modulating the acute phase response
#6446Method for diagnosing acute coronary syndrome
#6447Predicting diabetic nephropathy
#6448Methods for diagnosing and evaluating treatment of blood disorders
#6449Relationship of a specific metabolite to insulin resistance
#6450Methods for achieving a protective ACE2 expression level to treat kidney disease and hypertension
#6451NF-κB activating gene
#6452Secreted polypeptide species associated with cardiovascular disorders
#6453Diagnosis and prevention of fetal heart disease
#6454Assay for diabetes
#6455Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)
#6456Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis
#6457antibodies binding to a C-terminal fragment of apoliopoprotein E
#6458Diagnostics and therapeutics for diseases associated with n-acetylated alpha-linked acidic dipeptidase 2(naaladase 2)
#6459Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease
#6460Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations
#6461Methods and means for the treatment of disorders associated with cellular senescence
#6462Method of identifying responders to treatment with insulin sensitizers
#6463Secreted polypeptide species associatedwith cardiovascular disorders
#6464Target protein of antidiabetic and novel antidiabetic insuful corresponding thereto
#6465USES OF HUMAN ZVEN ANTAGONISTS
#6466Methods and compositions for diagnosis and /or prognosis in systemic inflammatory response syndromes
#6467Dietary calcium for reducing the production of reactive oxygen species
#6468Novel ubp8rp polypeptides and their use in the treatment of psoriasis
#6469Isolated nucleic acid sequence comprising SEQ ID NO: 14 and methods of using said nucleic acid sequence
#6470Method for the Early Detection of Renal Disease Using Proteomics
#6471Diagnosis method of endometriosis by detecting biochemical markers and usage of these biochemical markers
#6472Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
#6473Modeling of systemic inflammatory response to infection
#6474Development of human monoclonal antibodies and uses thereof
#6475Secreted polypeptide species reduced cardiovascular disorders
#6476Infertility assessment and treatment system
#6477Chemokine PANEC-2 polypeptides and compositions and methods related thereto
#6478Uses of human Zven proteins and polynucleotides
#6479Uses of lp-pla2 in combination to assess coronary risk
#6480Method of using GPR35 to identify metabolic-stabilizing compounds
#6481Polypeptide
#6482Methods of reducing the production of reactive oxygen species and methods of screening or identifying compounds and compositions that reduce the production of reactive oxygen species
#6483Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
#6484Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same
#6485Multiplex screening for lysosomal storage disorders (LSDs)
#6486Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#6487Method of reducing the likelihood of implantation failure during an assisted reproduction in a female subject in a need thereof
#6488Therapeutic agent for NGF
#6489Molecular determinants of myeloma bone disease and use thereof
#6490Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity
#6491Antibodies and methods for predicting dental caries
#6492Molecules that modulate Galphaq activity and methods of treating urinary incontinence
#6493Marker for inflammatory conditions
#6494Uses of human Zven proteins and polynucleotides
#6495Uses of humans zven proteins and polynucleotides
#6496Uses of human Zven proteins and polynucleotides
#6497Modulation of Epac, phospholipase Cepsilon, and phospholipase D to treat pain
#6498Methods for measuring the insulin receptor α subunit
#6499Novel genes and markers associated to type 2 diabetes mellitus
#6500Assessment method
#6501Methods
#6502Materials and methods for screening modulators of neural regeneration
#6503Diagnostic markers of wound infection III
#6504Diagnostic markers of wound infection II
#6505Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2)
#6506Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2)
#6507USES OF HUMAN ZVEN ANTAGONISTS
#6508USES OF HUMAN ZVEN ANTAGONISTS
#6509Methods of modulating gastrointestinal contractility
#6510Novel method of treatment of inflammatory skin conditions
#6511Method and kit for detection of autoimmune chronic urticaria
#6512Methods of detecting or diagnosing inflammatory bowel disease using prokineticin polynucleotides
#6513Use of human Zven proteins and polynucleotides
#6514sCD40L and placental growth factor (PLGF) used as a biochemical marker combination in cardiovascular diseases
#6515Biomarkers and assays for myocardial infarction
#6516Methods for predicting development of auto-immune diseases and treatment of same
#6517NS4 NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE FOR THE TREATMENT OF BODY WEIGHT DISORDERS
#6518Methods affecting markers in patients having vascular disease
#6519Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury
#6520Detection of NGAL in chronic renal disease
#6521Diagnostics and therapeutics for diseases associated with G-protein coupled receptor AdipoR1(AdipoR1)
#6522Diagnosis of liver pathology through assessment of protein glycosylation
#6523Method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
#6524Latex reagent for adiponectin analysis and method of adiponectin analysis
#6525Compositions and methods for the treatmetn of natural killer cell related diseases
#6526Tuberculosis antigen detection assays and vaccines
#6527Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same
#6528Methods for treating diabetes and related disorders using pde10a inhibitors
#6529Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
#6530Method for examining obesity or leanness
#6531Regulation of interaction between rapl and rap1
#6532Use of A33 antigens and jam-it
#6533Novel Integrin Ligand ITGL-TSP
#6534Novel Integrin Ligand ITGL-TSP
#6535Assessing insulin resistance using biomarkers
#6536Devices and methods for enrichment and alteration of circulating tumor cells and other particles
#6537Coagulation proteins, coagulation-anticoagulation protein complexes, derivatives thereof and their uses
#6538Interleukin-8 homologous polypeptides and therapeutic uses thereof
#6539Diagnosis of pre-eclampsia
#6540Coronary Endothelial Dysfunction
#6541Rapid test for glycated albumin in blood
#6542Mitochondrial markers of ischemia
#6543Multimarker panel for diabetes type 1 and 2
#6544Atlastin
#6545Methods of using bone morphogenic proteins as biomarkers for determining cartilage degeneration and aging
#6546Method for detecting vesicoureteral reflux or interstitial cystitis
#654799 human secreted proteins
#6548Use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferative diseases
#6549Method of diagnosing disease relating to endometriosis
#6550Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
#6551Complement C3 precursor biopolymer markers indicative of insulin resistance
#6552Protein biopolymer markers predictive of insulin resistance
#6553Method for identification of somatic stem cells
#6554Secreted polypeptide species associated with cardiovascular disorders
#6555ATM kinase compositions and methods
#6556Inflammatory skin disease-related slurp-2 gene and utilization thereof
#6557Method for diagnosing diabetes type 2 using standardized mixed meal and calculated index values
#6558Synthetic active peptide fragments
#6559Method and means for treatment of osteoarthritis
#6560Methods for modulating bone tissue formation, orthogenic agents and pharmaceutical compositions
#6561Method for detection of a disease-specific combinatorial molecular pattern motif in a tissue sample of a patient's skin
#6562Methods and kits for the diagnosis of acute coronary syndrome
#6563Use of cytokine receptors as biomarkers and therapeutic targets in human cancer
#6564Method of grading disease by Fourier Transform Infrared Spectroscopy
#6565AUTOMATIC ANALYSIS OF CELLULAR SAMPLES
#6566Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor
#6567Modulation of osteoblast activity by fhl2
#6568Remedy or preventive for kidney disease and method of diagnosing kidney disease
#6569Methods of modulating β cell function
#6570Treatment and Diagnosis of Insulin-Resistant States
#6571Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
#6572Methods and kits for drug screening and toxicity testing using promoter-reporter cells derived from embryonic stem cells
#6573Sequence #115 as a target for identifying weight modulating compounds
#6574Methods of identifying active BRM expression-promoting HDAC inhibitors
#6575Methods of diagnosing & treating diabetes and insulin resistance
#6576Proteins encoded by the severe acute respiratory syndrome (SARS) coronavirus and a role in apoptosis
#6577Diagnostics and therapeutics for diseases associated with mosaic serine protease (msp)
#6578Pharmaceutical preparations containing thiazolidinediones showing new therapeutic indications
#6579PROXIMAL MARKERS OF ARTERIAL THROMBOSIS AND INFLAMMATION FOR RISK STRATIFICATION OF CORONARY HEART DISEASE
#6580PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
#6581Non-invasive marker for liver function and disease
#6582Method for monitoring coagulability and hypercoagulable states
#6583Lectin binding to choroidal neovascularization
#6584Method and markers for the diagnosis of renal diseases
#6585Aortic carboxypeptidase-like polypeptide
#6586Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
#6587Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
#6588RelA-ASSOCIATED INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
#6589Method for analyzing biological data sets
#6590Anti-feline albumin antibodies
#659144 human secreted proteins
#6592Diagnostics and therapeutics for diseases associated with phosphodiesterase 1b (pde1b)
#6593Antibody to the human OX40 receptor
#6594Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
#6595Novel human beta-2 integrin alpha subunit
#6596WSX receptor agonist antibodies
#6597Monitoring two dimensions of diabetes pathogenesis
#6598Assay for neuromuscular diseases
#6599Detection of antigen specific immunocomplexes
#6600Method for diagnosing insulin resistance from nasal secretions